Pre-existing T cell immunity determines the frequency and magnitude of cellular immune response to two doses of mRNA vaccine against SARS-CoV-2José L. Casado, Alejandro Vallejo, Adrián Martín-Hondarza et al.|Vaccine X|2022Cited by 18
T‐cell response after first dose of BNT162b2 SARS‐CoV‐2 vaccine among healthcare workers with previous infection or cross‐reactive immunityJosé L. Casado, Alejandro Vallejo, Johannes Häemmerle et al.|Clinical & Translational Immunology|2021Cited by 16